找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient; An Evidence-Based Gu Christine N. Duncan,Julie-An M. Talano,J

[復(fù)制鏈接]
查看: 44538|回復(fù): 60
樓主
發(fā)表于 2025-3-21 19:44:38 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient
副標(biāo)題An Evidence-Based Gu
編輯Christine N. Duncan,Julie-An M. Talano,Jennifer A.
視頻videohttp://file.papertrans.cn/240/239925/239925.mp4
概述One of the first multi-disciplinary resources on the critical care of immunocompromised children.Addresses important knowledge gaps in the current literature.Written by experts from different discipli
圖書封面Titlebook: Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient; An Evidence-Based Gu Christine N. Duncan,Julie-An M. Talano,J
描述This volume provides a comprehensive overview of critical care of the pediatric immunocompromised hematology-oncology patient. The text focuses on unique aspects of the pediatric immunocompromised patient that predisposes the child to significant illness, and presents critical care management strategies specific to the patient population. In addition to chapters on oncology, primary immune deficiency, immunocompromised hematology, and hematopoietic cell transplant patients, the book covers the changing landscape of ICU care, pharmacologic considerations, and psychological and social aspects of the critical care of hematology-oncology patients..Written by experts from a range of disciplines,?.Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide.?is a valuable resource for clinicians and practitioners who treat this patient population.
出版日期Book 2019
關(guān)鍵詞leukemia; sickle cell disease; hematopoietic cell transplant; sepsis; post-traumatic stress disorder; pal
版次1
doihttps://doi.org/10.1007/978-3-030-01322-6
isbn_ebook978-3-030-01322-6
copyrightSpringer International Publishing 2019
The information of publication is updating

書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient影響因子(影響力)




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient影響因子(影響力)學(xué)科排名




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient網(wǎng)絡(luò)公開度




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient被引頻次




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient被引頻次學(xué)科排名




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient年度引用




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient年度引用學(xué)科排名




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient讀者反饋




書目名稱Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:17:26 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:05:03 | 只看該作者
地板
發(fā)表于 2025-3-22 07:37:17 | 只看該作者
Carola Pantenburg,Gerhard Peterns. Prompt recognition and management of these complications are imperative to achieve the best possible outcomes. The optimal screening regimen for cardiac complications has yet to be established, but there are promising new biomarkers and imaging modalities that may aid in more prompt diagnosis and intervention in the future.
5#
發(fā)表于 2025-3-22 09:12:11 | 只看該作者
6#
發(fā)表于 2025-3-22 14:06:15 | 只看該作者
7#
發(fā)表于 2025-3-22 17:41:35 | 只看該作者
8#
發(fā)表于 2025-3-22 23:26:50 | 只看該作者
9#
發(fā)表于 2025-3-23 01:42:52 | 只看該作者
10#
發(fā)表于 2025-3-23 05:51:12 | 只看該作者
Cardiac Dysfunction in Hematology Oncology and Hematopoietic Cell Transplant Patientsns. Prompt recognition and management of these complications are imperative to achieve the best possible outcomes. The optimal screening regimen for cardiac complications has yet to be established, but there are promising new biomarkers and imaging modalities that may aid in more prompt diagnosis and intervention in the future.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-16 22:21
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
潜江市| 新乡市| 禄丰县| 贞丰县| 龙岩市| 渝中区| 梧州市| 平果县| 太湖县| 墨脱县| 南昌市| 尼木县| 钟祥市| 清水河县| 河津市| 甘谷县| 监利县| 秦安县| 墨江| 阜宁县| 龙里县| 浮梁县| 泰宁县| 临沂市| 海晏县| 泰兴市| 巢湖市| 六安市| 延津县| 茂名市| 宜丰县| 莱芜市| 攀枝花市| 敦化市| 韶山市| 应城市| 恩施市| 静安区| 盱眙县| 新干县| 鹿邑县|